PATENT CLAIM ANALYSIS

Application Number: 15761861
Application Type: Utility
Filing Date: 2018-05
Publication Date: 2018-08
Patent Classification: ["514", "229800"]

Abstract:
Disclosed are a quinoline derivative, and a pharmaceutical composition, a preparation method and a use thereof. The quinoline derivative of the present invention has a c-Met inhibitory activity and can be used for the treatment, relieving and/or prevention of cancers or similar diseases.

Claim (Index 10):
A method for treating, alleviating and/or preventing cancer in a subject in need thereof, comprising: administering an effective amount of the quinoline derivative, the tautomer, the mesomer, the racemate, the enantiomer, the diastereomer, or the pharmaceutically acceptable salt thereof according to  claim 1  to the subject;\n the cancer can be bladder cancer, breast cancer, colon cancer, kidney cancer, liver cancer, lung cancer, skin cancer, epidermal squamous cell carcinoma, gastric cancer, hematopoietic tumor of lymph system, hematopoietic tumor of bone marrow system, mesenchymal tumor, and tumor of central and peripheral nervous system.

Metadata:
- Claim Count in Document: 20.0
- Percentile: 93.0
- Lexical Diversity: 1.37143
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['15736898', '15030125', '14365497', '15766985', '14889092']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8010829289828567
- 35 USC 102 Novelty (BERT): 0.5277120509400759
- Combined Prediction Score: 0.7737458411785786
- Mean Citation Score: 338.76736
- Max Citation Score: 352.5189
- Similarity Product: 254.36994655607344

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test